Solutions_Erectile | 合法醫療器材資訊網

ErectileDysfunctionShockWaveTherapy(EDSWT)isaninnovativeapproachtovasculogenicED,deliveredbyMedispec'sED1000,adevicethatuses ...

Vasculogenic and diabetic ED patients will benefit from EDSWT – those who are responsive to PDE5 inhibitors as well as those who are unresponsive. For the latter, which includes a substantial number of severe ED patients, the only solution to date are vacuum pumps, injections and perhaps implants. EDSWT therapy brings hope to those patients, by allowing more than 70% of them to become responsive to PDE5 inhibitors. As “end-stage” ED patients, they will be able to enjoy normal sexual functionality.

With over 50% of men aged 40-70 suffering from ED, and even more from transient ED, Medispec’s breakthrough therapeutic system can bring lasting improvement in erectile function and new sexual spontaneity to millions – painlessly, naturally and safely.